| - GRCh37:
- Chr11:45832638
- GRCh38:
- Chr11:45811087
| SLC35C1 | V270M, V283M | Leukocyte adhesion deficiency type II | Uncertain significance (Oct 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827353-47804770
| MADD, ZNF408, MAPK8IP1, MDK, MTCH2, PEX16, MADD-AS1, SPI1, ACP2, AGBL2, AMBRA1, ARFGAP2, ARHGAP1, ATG13, C1QTNF4, CELF1, CHRM4, CKAP5, CREB3L1, CRY2, CSTPP1, DDB2, DGKZ, F2, FAM180B, FNBP4, FREY1, HARBI1, KBTBD4, LARGE2, LRP4, MYBPC3, NDUFS3, NR1H3, NUP160, PACSIN3, PHF21A, PSMC3, PTPMT1, RAPSN, SLC35C1, SLC39A13 | | Leukocyte adhesion deficiency type II | Pathogenic (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827374
- GRCh38:
- Chr11:45805823
| SLC35C1 | R8W | Leukocyte adhesion deficiency type II | Uncertain significance (Jun 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827643
- GRCh38:
- Chr11:45806092
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Sep 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832529
- GRCh38:
- Chr11:45810978
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827858
- GRCh38:
- Chr11:45806307
| SLC35C1 | Y156C, Y169C | Leukocyte adhesion deficiency type II | Uncertain significance (May 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827610
- GRCh38:
- Chr11:45806059
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827607
- GRCh38:
- Chr11:45806056
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Jul 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832745
- GRCh38:
- Chr11:45811194
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Jan 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827661
- GRCh38:
- Chr11:45806110
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Jul 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832736
- GRCh38:
- Chr11:45811185
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Jan 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832496
- GRCh38:
- Chr11:45810945
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832384
- GRCh38:
- Chr11:45810833
| SLC35C1 | G198A, G185A | Leukocyte adhesion deficiency type II | Uncertain significance (May 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832386
- GRCh38:
- Chr11:45810835
| SLC35C1 | T186A, T199A | Leukocyte adhesion deficiency type II | Uncertain significance (May 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827568
- GRCh38:
- Chr11:45806017
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Apr 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832311
- GRCh38:
- Chr11:45810760
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Apr 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827412
- GRCh38:
- Chr11:45805861
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (May 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827733
- GRCh38:
- Chr11:45806182
| SLC35C1 | M114I, M127I | Leukocyte adhesion deficiency type II | Uncertain significance (Feb 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832645
- GRCh38:
- Chr11:45811094
| SLC35C1 | G272V, G285V | Leukocyte adhesion deficiency type II | Uncertain significance (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827907
- GRCh38:
- Chr11:45806356
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827561
- GRCh38:
- Chr11:45806010
| SLC35C1 | L70R, L57R | Leukocyte adhesion deficiency type II | Uncertain significance (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827712
- GRCh38:
- Chr11:45806161
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832707
- GRCh38:
- Chr11:45811156
| SLC35C1 | A293S, A306S | Leukocyte adhesion deficiency type II | Uncertain significance (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827556
- GRCh38:
- Chr11:45806005
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Dec 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827394
- GRCh38:
- Chr11:45805843
| SLC35C1 | M1I, M14I | Leukocyte adhesion deficiency type II | Uncertain significance (Jul 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832371
- GRCh38:
- Chr11:45810820
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Jul 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832413
- GRCh38:
- Chr11:45810862
| SLC35C1 | C195R, C208R | Leukocyte adhesion deficiency type II | Uncertain significance (Jun 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827623
- GRCh38:
- Chr11:45806072
| SLC35C1 | L78F, L91F | Leukocyte adhesion deficiency type II | Uncertain significance (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832542
- GRCh38:
- Chr11:45810991
| SLC35C1 | E238K, E251K | Leukocyte adhesion deficiency type II | Uncertain significance (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832627
- GRCh38:
- Chr11:45811076
| SLC35C1 | A279G, A266G | Leukocyte adhesion deficiency type II | Uncertain significance (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827682
- GRCh38:
- Chr11:45806131
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Aug 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832340
- GRCh38:
- Chr11:45810789
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Jan 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827638
- GRCh38:
- Chr11:45806087
| SLC35C1 | A83T, A96T | Leukocyte adhesion deficiency type II | Uncertain significance (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832795
- GRCh38:
- Chr11:45811244
| SLC35C1 | S335F, S322F | Leukocyte adhesion deficiency type II | Uncertain significance (Oct 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832870
- GRCh38:
- Chr11:45811319
| SLC35C1 | S347N, S360N | Leukocyte adhesion deficiency type II | Uncertain significance (Aug 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827696
- GRCh38:
- Chr11:45806145
| SLC35C1 | R115H, R102H | Leukocyte adhesion deficiency type II | Uncertain significance (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827574
- GRCh38:
- Chr11:45806023
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827763
- GRCh38:
- Chr11:45806212
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Mar 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827460
- GRCh38:
- Chr11:45805909
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Sep 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832796
- GRCh38:
- Chr11:45811245
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Sep 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832394
- GRCh38:
- Chr11:45810843
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Jan 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827805
- GRCh38:
- Chr11:45806254
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Sep 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827688
- GRCh38:
- Chr11:45806137
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Feb 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827692
- GRCh38:
- Chr11:45806141
| SLC35C1 | A101P, A114P | Leukocyte adhesion deficiency type II | Uncertain significance (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827655
- GRCh38:
- Chr11:45806104
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Sep 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832306-45832308
- GRCh38:
- Chr11:45810755-45810757
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832871
- GRCh38:
- Chr11:45811320
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Dec 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832463
- GRCh38:
- Chr11:45810912
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832799
- GRCh38:
- Chr11:45811248
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Aug 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827847
- GRCh38:
- Chr11:45806296
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Oct 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827724
- GRCh38:
- Chr11:45806173
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827559
- GRCh38:
- Chr11:45806008
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Jan 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827505
- GRCh38:
- Chr11:45805954
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832715
- GRCh38:
- Chr11:45811164
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Sep 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832533
- GRCh38:
- Chr11:45810982
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827760
- GRCh38:
- Chr11:45806209
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832421
- GRCh38:
- Chr11:45810870
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827583
- GRCh38:
- Chr11:45806032
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Apr 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827491
- GRCh38:
- Chr11:45805940
| SLC35C1 | L47F, L34F | Leukocyte adhesion deficiency type II | Uncertain significance (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832569
- GRCh38:
- Chr11:45811018
| SLC35C1 | Q260*, Q247* | Leukocyte adhesion deficiency type II | Likely pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832668
- GRCh38:
- Chr11:45811117
| SLC35C1 | P293T, P280T | Leukocyte adhesion deficiency type II | Uncertain significance (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832809
- GRCh38:
- Chr11:45811258
| SLC35C1 | V327I, V340I | Leukocyte adhesion deficiency type II | Uncertain significance (Mar 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832725
- GRCh38:
- Chr11:45811174
| SLC35C1 | V299M, V312M | Leukocyte adhesion deficiency type II | Uncertain significance (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832876
- GRCh38:
- Chr11:45811325
| SLC35C1 | M362T, M349T | Leukocyte adhesion deficiency type II | Uncertain significance (Jun 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827762
- GRCh38:
- Chr11:45806211
| SLC35C1 | Y137S, Y124S | Leukocyte adhesion deficiency type II | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832431
- GRCh38:
- Chr11:45810880
| SLC35C1 | I201V, I214V | Leukocyte adhesion deficiency type II | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832560
- GRCh38:
- Chr11:45811009
| SLC35C1 | D257Y, D244Y | Leukocyte adhesion deficiency type II | Uncertain significance (Oct 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832508-45832509
- GRCh38:
- Chr11:45810957-45810958
| SLC35C1 | I240V, I227V | Leukocyte adhesion deficiency type II | Likely benign (Oct 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827366
- GRCh38:
- Chr11:45805815
| SLC35C1 | P5L | Leukocyte adhesion deficiency type II | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827759
- GRCh38:
- Chr11:45806208
| SLC35C1 | K136R, K123R | Leukocyte adhesion deficiency type II | Uncertain significance (Aug 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832447
- GRCh38:
- Chr11:45810896
| SLC35C1 | V206A, V219A | Leukocyte adhesion deficiency type II | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827434
- GRCh38:
- Chr11:45805883
| SLC35C1 | A15T, A28T | Leukocyte adhesion deficiency type II | Uncertain significance (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827815-45827816
- GRCh38:
- Chr11:45806264-45806265
| SLC35C1 | | Leukocyte adhesion deficiency type II | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832837
- GRCh38:
- Chr11:45811286
| SLC35C1 | P349L, P336L | Leukocyte adhesion deficiency type II | Uncertain significance (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827578
- GRCh38:
- Chr11:45806027
| SLC35C1 | V63L, V76L | Leukocyte adhesion deficiency type II | Uncertain significance (Oct 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827437
- GRCh38:
- Chr11:45805886
| SLC35C1 | N16H, N29H | Leukocyte adhesion deficiency type II | Uncertain significance (Oct 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832567
- GRCh38:
- Chr11:45811016
| SLC35C1 | A259V, A246V | Leukocyte adhesion deficiency type II | Uncertain significance (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827785
- GRCh38:
- Chr11:45806234
| SLC35C1 | V132M, V145M | Leukocyte adhesion deficiency type II, Inborn genetic diseases | Uncertain significance (Feb 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:45832844
- GRCh38:
- Chr11:45811293
| SLC35C1 | E338D, E351D | Leukocyte adhesion deficiency type II | Uncertain significance (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832465
- GRCh38:
- Chr11:45810914
| SLC35C1 | G212D, G225D | Leukocyte adhesion deficiency type II | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832747
- GRCh38:
- Chr11:45811196
| SLC35C1 | K306T, K319T | Leukocyte adhesion deficiency type II | Uncertain significance (Jul 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832497
- GRCh38:
- Chr11:45810946
| SLC35C1 | V223I, V236I | Leukocyte adhesion deficiency type II | Uncertain significance (Sep 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832611
- GRCh38:
- Chr11:45811060
| SLC35C1 | G274S, G261S | Leukocyte adhesion deficiency type II | Uncertain significance (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832730-45832732
- GRCh38:
- Chr11:45811179-45811181
| SLC35C1 | Y302del, Y315del | Leukocyte adhesion deficiency type II | Uncertain significance (Oct 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827362
- GRCh38:
- Chr11:45805811
| SLC35C1 | A4T | Leukocyte adhesion deficiency type II | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832812
- GRCh38:
- Chr11:45811261
| SLC35C1 | R341fs, R328fs | Leukocyte adhesion deficiency type II | Uncertain significance (Oct 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827682
- GRCh38:
- Chr11:45806131
| SLC35C1 | D97E, D110E | Leukocyte adhesion deficiency type II | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827887
- GRCh38:
- Chr11:45806336
| SLC35C1 | G179R, G166R | Leukocyte adhesion deficiency type II | Uncertain significance (Aug 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827612
- GRCh38:
- Chr11:45806061
| SLC35C1 | L87P, L74P | Leukocyte adhesion deficiency type II | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832632
- GRCh38:
- Chr11:45811081
| SLC35C1 | G268S, G281S | Leukocyte adhesion deficiency type II | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832678
- GRCh38:
- Chr11:45811127
| SLC35C1 | H283R, H296R | Leukocyte adhesion deficiency type II | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr11:45832682
- GRCh38:
- Chr11:45811131
| SLC35C1 | N284K, N297K | Leukocyte adhesion deficiency type II | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832649
- GRCh38:
- Chr11:45811098
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Oct 5, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827550
- GRCh38:
- Chr11:45805999
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Aug 26, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832730
- GRCh38:
- Chr11:45811179
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Oct 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832637
- GRCh38:
- Chr11:45811086
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Apr 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45832724
- GRCh38:
- Chr11:45811173
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Feb 5, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827706
- GRCh38:
- Chr11:45806155
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Aug 5, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827700
- GRCh38:
- Chr11:45806149
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:45827853
- GRCh38:
- Chr11:45806302
| SLC35C1 | | Leukocyte adhesion deficiency type II | Likely benign (Nov 3, 2019) | criteria provided, single submitter |